Hypha Labs, Inc. (FUNI)
2025-06-30 | 2025-03-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | - | - | - | |
| Cost of sales | - | - | - | |
| Gross profit | - | - | - | |
| Professional fees | 454,344 | 603,695 | 280,153 | |
| General and administrative | 81,683 | 65,467 | 1,025,111 | |
| Total operating expenses | 536,027 | 669,162 | 1,305,264 | |
| Operating loss | -536,027 | -669,162 | -1,305,264 | |
| Other expense | - | - | 20,003 | |
| Recovery of previously written off receivables | - | 50,000 | - | |
| Interest income | - | - | 8,000 | |
| Interest expense | 25,996 | 22,660 | 22,374 | |
| Loss on debt extinguishment | - | - | - | |
| Gain on sale of subsidiary assets | - | - | - | |
| Total other income (expense) | -25,996 | 27,340 | -34,377 | |
| Net loss from continuing operations before income taxes | -562,023 | -641,822 | - | |
| Provision for income taxes | - | - | - | |
| Net loss from continuing operations | -562,023 | -641,822 | - | |
| Net income from discontinued operations, net of taxes | - | - | - | |
| Net loss from continuing operations | - | - | -1,339,641 | |
| Net income (loss) | -562,023 | -641,822 | -1,339,641 | |
| Net income (loss) per share basic | - | -0.01 | -0.01 | |
| Net income (loss) per share diluted | - | -0.01 | -0.01 | |
| Weighted average number of common shares outstanding basic | 136,951,495 | 131,081,825 | 124,617,477 | |
| Weighted average number of common shares outstanding fully diluted | 136,951,495 | 131,081,825 | 124,617,477 | |